Aurobindo Pharma share price up 0.26%


The shares of Ltd. traded 0.26 percent at Rs 731.7 around 1:21 p.m. (IST) on Wednesday. The stock had closed at Rs 729.8 in the previous session. The benchmark Sensex shares traded 486.13 points higher to 60,770.44 around the same time.

The script has fallen 9.79 percent over the past year to date, while the 30-stock index has gained 62.52 percent over the same period.

The 52 week high share price was Rs 1,063.75 and the 52 week low price was Rs 660.1.

Over-the-counter trading volume stood at 34,936 shares, while it cited a price-to-earnings ratio of 8.06, EPS of 90.87 and price-to-book value of 2.36. In the Nifty50 pack, 38 stocks traded in the green, while 11 stocks were in the red.

Promoter / FII Holding
The promoters held 51.83 percent of the company’s capital as of September 30, 2021, while foreign investors and ownership of FMs amounted to 23.41 percent and 9.28 percent respectively.

Key financial data
For the quarter ended June 30, 2021, the company reported consolidated sales of Rs 5,783.29 crore, down 4.87% from Rs 6,079.6 crore in the previous quarter and down 4.26% compared to Rs 6,040.37 crore for the quarter of the previous year. The company reported net profit of Rs 769.97 crore for the last quarter.

Technical indicators

The MACD signaled a bullish bias on the meter. The MACD is known to signal trend reversals in the securities or indices being traded. This is the difference between the 26-day and 12-day exponential moving averages. A nine-day exponential moving average, called a signal line, is plotted above the MACD to reflect opportunities to “buy” or “sell”. When the MACD crosses below the signal line, it gives a bearish signal, indicating that the price of the security may experience a downward movement and vice versa.

About Margie Peters

Check Also

Sensex down 674 points during the day, Nifty below 15,500

Benchmarks were trading more than 1% lower on Wednesday afternoon. The market started off on …

Leave a Reply

Your email address will not be published.